Status:
RECRUITING
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Gastroenteropancreatic Neuroendocrine Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a heterogeneous group of neoplasms that arise from the endocrine cells of the gastroenteropancreatic tract. The diagnostic work-up of thes...
Eligibility Criteria
Inclusion
- Patients with either histological diagnosis of GEP-NET at radiologic imaging and referred to 68Ga-DOTATOC PET;
- Age \> 18 years old;
- Willing to provide a signed informed consent.
Exclusion
- Controindications to MR study (i.e. Pacemaker);
- Age\< 18 years old.
Key Trial Info
Start Date :
September 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 5 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06155318
Start Date
September 5 2019
End Date
May 5 2029
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italy, 20132